General Information of Drug Off-Target (DOT) (ID: OT7USYCY)

DOT Name Vesicle transport protein SEC20 (BNIP1)
Synonyms BCL2/adenovirus E1B 19 kDa protein-interacting protein 1; Transformation-related gene 8 protein; TRG-8
Gene Name BNIP1
Related Disease
Breast cancer ( )
Breast carcinoma ( )
High blood pressure ( )
Open-angle glaucoma ( )
Cervical carcinoma ( )
Amyotrophic lateral sclerosis ( )
Frontotemporal dementia ( )
Progressive supranuclear palsy ( )
UniProt ID
SEC20_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Pfam ID
PF03908
Sequence
MAAPQDVHVRICNQEIVKFDLEVKALIQDIRDCSGPLSALTELNTKVKEKFQQLRHRIQD
LEQLAKEQDKESEKQLLLQEVENHKKQMLSNQASWRKANLTCKIAIDNLEKAELLQGGDL
LRQRKTTKESLAQTSSTITESLMGISRMMAQQVQQSEEAMQSLVTSSRTILDANEEFKSM
SGTIQLGRKLITKYNRRELTDKLLIFLALALFLATVLYIVKKRLFPFL
Function
As part of a SNARE complex may be involved in endoplasmic reticulum membranes fusion and be required for the maintenance of endoplasmic reticulum organization. Also plays a role in apoptosis. It is for instance required for endoplasmic reticulum stress-induced apoptosis. As a substrate of RNF185 interacting with SQSTM1, might also be involved in mitochondrial autophagy (Probable).
Tissue Specificity
Isoform 1 is highly expressed in heart, brain, liver skeletal muscle and pancreas. Isoform 3 is moderately expressed in placenta, lung and kidney. Isoform 4 is highly expressed in testis and small intestine.
KEGG Pathway
S.RE interactions in vesicular transport (hsa04130 )
Reactome Pathway
COPI-dependent Golgi-to-ER retrograde traffic (R-HSA-6811434 )

Molecular Interaction Atlas (MIA) of This DOT

8 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Breast cancer DIS7DPX1 Strong Altered Expression [1]
Breast carcinoma DIS2UE88 Strong Altered Expression [1]
High blood pressure DISY2OHH Strong Biomarker [2]
Open-angle glaucoma DISSZEE8 Strong Genetic Variation [3]
Cervical carcinoma DIST4S00 moderate Biomarker [4]
Amyotrophic lateral sclerosis DISF7HVM Limited Biomarker [5]
Frontotemporal dementia DISKYHXL Limited Genetic Variation [5]
Progressive supranuclear palsy DISO5KRQ Limited Genetic Variation [5]
------------------------------------------------------------------------------------
⏷ Show the Full List of 8 Disease(s)
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
13 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate affects the expression of Vesicle transport protein SEC20 (BNIP1). [6]
Ciclosporin DMAZJFX Approved Ciclosporin increases the expression of Vesicle transport protein SEC20 (BNIP1). [7]
Acetaminophen DMUIE76 Approved Acetaminophen decreases the expression of Vesicle transport protein SEC20 (BNIP1). [8]
Vorinostat DMWMPD4 Approved Vorinostat decreases the expression of Vesicle transport protein SEC20 (BNIP1). [9]
Fluorouracil DMUM7HZ Approved Fluorouracil increases the expression of Vesicle transport protein SEC20 (BNIP1). [9]
Resveratrol DM3RWXL Phase 3 Resveratrol increases the expression of Vesicle transport protein SEC20 (BNIP1). [10]
Camptothecin DM6CHNJ Phase 3 Camptothecin increases the expression of Vesicle transport protein SEC20 (BNIP1). [9]
Genistein DM0JETC Phase 2/3 Genistein increases the expression of Vesicle transport protein SEC20 (BNIP1). [10]
(+)-JQ1 DM1CZSJ Phase 1 (+)-JQ1 decreases the expression of Vesicle transport protein SEC20 (BNIP1). [11]
Leflunomide DMR8ONJ Phase 1 Trial Leflunomide increases the expression of Vesicle transport protein SEC20 (BNIP1). [12]
Bisphenol A DM2ZLD7 Investigative Bisphenol A decreases the expression of Vesicle transport protein SEC20 (BNIP1). [13]
Milchsaure DM462BT Investigative Milchsaure increases the expression of Vesicle transport protein SEC20 (BNIP1). [14]
Paraquat DMR8O3X Investigative Paraquat decreases the expression of Vesicle transport protein SEC20 (BNIP1). [15]
------------------------------------------------------------------------------------
⏷ Show the Full List of 13 Drug(s)

References

1 NIP1/DUOXA1 expression in epithelial breast cancer cells: regulation of cell adhesion and actin dynamics.Breast Cancer Res Treat. 2010 Feb;119(3):773-86. doi: 10.1007/s10549-009-0372-7. Epub 2009 Mar 26.
2 A neural network model for constructing endophenotypes of common complex diseases: an application to male young-onset hypertension microarray data.Bioinformatics. 2009 Apr 15;25(8):981-8. doi: 10.1093/bioinformatics/btp106. Epub 2009 Feb 23.
3 A multiethnic genome-wide association study of primary open-angle glaucoma identifies novel risk loci.Nat Commun. 2018 Jun 11;9(1):2278. doi: 10.1038/s41467-018-04555-4.
4 BNIP1 inhibits cell proliferation, migration and invasion, and promotes apoptosis by mTOR in cervical cancer cells.Eur Rev Med Pharmacol Sci. 2019 Feb;23(4):1397-1407. doi: 10.26355/eurrev_201902_17096.
5 Selective Genetic Overlap Between Amyotrophic Lateral Sclerosis and Diseases of the Frontotemporal Dementia Spectrum.JAMA Neurol. 2018 Jul 1;75(7):860-875. doi: 10.1001/jamaneurol.2018.0372.
6 Gene Expression Regulation and Pathway Analysis After Valproic Acid and Carbamazepine Exposure in a Human Embryonic Stem Cell-Based Neurodevelopmental Toxicity Assay. Toxicol Sci. 2015 Aug;146(2):311-20. doi: 10.1093/toxsci/kfv094. Epub 2015 May 15.
7 Comparison of HepG2 and HepaRG by whole-genome gene expression analysis for the purpose of chemical hazard identification. Toxicol Sci. 2010 May;115(1):66-79.
8 Multiple microRNAs function as self-protective modules in acetaminophen-induced hepatotoxicity in humans. Arch Toxicol. 2018 Feb;92(2):845-858.
9 Development and validation of the TGx-HDACi transcriptomic biomarker to detect histone deacetylase inhibitors in human TK6 cells. Arch Toxicol. 2021 May;95(5):1631-1645. doi: 10.1007/s00204-021-03014-2. Epub 2021 Mar 26.
10 Gene expression profiling in Ishikawa cells: a fingerprint for estrogen active compounds. Toxicol Appl Pharmacol. 2009 Apr 1;236(1):85-96.
11 Synergistic effect of JQ1 and rapamycin for treatment of human osteosarcoma. Int J Cancer. 2015 May 1;136(9):2055-64.
12 Endoplasmic reticulum stress and MAPK signaling pathway activation underlie leflunomide-induced toxicity in HepG2 Cells. Toxicology. 2017 Dec 1;392:11-21.
13 Bisphenol A induces DSB-ATM-p53 signaling leading to cell cycle arrest, senescence, autophagy, stress response, and estrogen release in human fetal lung fibroblasts. Arch Toxicol. 2018 Apr;92(4):1453-1469.
14 Transcriptional profiling of lactic acid treated reconstructed human epidermis reveals pathways underlying stinging and itch. Toxicol In Vitro. 2019 Jun;57:164-173.
15 Identification of genes associated with paraquat-induced toxicity in SH-SY5Y cells by PCR array focused on apoptotic pathways. J Toxicol Environ Health A. 2008;71(22):1457-67. doi: 10.1080/15287390802329364.